Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New pain cocktail could help kids recover faster after appendix removal

NCT ID NCT07088900

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 41 times

Summary

This study looks at whether adding dexmedetomidine to the standard numbing drug bupivacaine in a caudal block (a type of pain shot near the tailbone) can give children longer pain relief after open appendix surgery. Sixty children will be randomly assigned to get either the combo or bupivacaine alone. The main goal is to see how long it takes before they need extra pain medicine.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Ain Shams university hospitals

    RECRUITING

    Cairo, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

dexmedetomidine added to bupivacaine

What this could lead to

If it works, this could provide longer-lasting pain relief and a smoother recovery for children after appendix surgery.

What could go wrong

This is a small, early-phase study with only 60 children, so results may not apply to everyone. There is also a risk of side effects like low blood pressure or slow heart rate from the added medication.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.